Format

Send to

Choose Destination
See comment in PubMed Commons below
Immunotherapy. 2011 Mar;3(3):435-41. doi: 10.2217/imt.10.111.

More than just a T-box: the role of T-bet as a possible biomarker and therapeutic target in autoimmune diseases.

Author information

1
Department of Biology, University of Texas at San Antonio, TX 78249, USA.

Abstract

T-bet was initially described as a T-box transcription factor with an essential role in orchestrating Th1 cell differentiation. Subsequently, it was determined that T-bet controls the expression of numerous cytokines and their receptors, adhesion molecules and chemokine receptors, and therefore determines the differentiation and development status of many types of immune cells. The critical role of T-bet in autoimmune diseases, particularly multiple sclerosis and its animal model experimental autoimmune encephalomyelitis, implicates it as a potential biomarker for pathogenic T cells as well as a therapeutic drug target.

PMID:
21395384
PMCID:
PMC3160828
DOI:
10.2217/imt.10.111
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Support Center